Altimmune ALT Q1 2025 earnings
Reported May 13, 2025 · Before market open
Revenue estimate$560.0
EPS estimate-$0.35
Next report
Aug 11, 2026 (In 3 weeks)Revenue estimate$1.8K
EPS estimate-$0.15
Financials
Q1 2025Valuation & ratios
Versus estimates
Revenue
Diluted EPS
Ask the moment Altimmune reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Altimmune report Q1 2025 earnings?
- Altimmune (ALT) reported Q1 2025 earnings on May 13, 2025 before market open.
- What were Altimmune's Q1 2025 revenue and EPS?
- Altimmune reported revenue of $5.0K and diluted EPS of $-0.26 for Q1 2025.
- Did Altimmune beat estimates in Q1 2025?
- Revenue beat the consensus estimate of $560.0 by $4.4K. EPS beat the consensus estimate of $-0.35 by $0.09.
- How did Altimmune's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 0.0% from $5.0K a year earlier and diluted EPS grew 23.5% from $-0.34.
- Where can I find Altimmune's Q1 2025 SEC filings?
- You can read the 10-Q periodic report (0001326190-25-000034) directly on SEC EDGAR. The filing index links above go to sec.gov.